ReviewJournal of the Egyptian National Cancer Institute2025

Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming.

Ravi Adusumalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.